For acute care physicians , the current approach and disease indications for treatment with anticoagulants are particularly relevant. When a patient treated with anticoagulants presents to the emergency department, intensive care unit, or operating room with severe, uncontrolled bleeding, the achievement of rapid controlled hemostasis is extremely important to saving the patient’s life.

Detailed discussion regarding the current treatment of critically-ill or critically-injured patients with life-threatening bleeding that present to the ED or critical care unit.

Management of severe bleeding in patients taking oral anticoagulants is complicated. Acute care physicians must be knowledgeable about the individual oral anticoagulant agents, the general management of anticoagulant-associated bleeding, and the strategies for effective use of factor repletion and specific reversal agents.

Expert specialists from Emergency Cardiovascular and Neurovascular Care, Pre-hospital Emergency Medical Services, Emergency Medicine Operations, Nephrology, Hospital Medicine, Neurocritical Care, Cardiology, Medical Critical Care, and Trauma and Surgical Critical Care discuss the implications of managing hyperkalemia in their field with patients in the Emergency Department, Critical Care Units, and the Cardiology Clinic.

For emergency physicians, critical care physicians, hospitalists, cardiologists, internists, surgeons, and family physicians, the current approach and disease indications for treatment with anticoagulants such as coumadin, Factor IIa, and Factor Xa inhibitors are particularly relevant. When a patient treated with anticoagulants presents to the Emergency Department, Intensive Care Unit, or Operating Room with severe, uncontrollable bleeding, achieving rapid, controlled hemostasis is critically important to saving the patient’s life.

In this EMCREG-International Monograph you will find a detailed discussion regarding the treatment of patients requiring anticoagulation and the reversal of anticoagulation for patients with severe bleeding.

In this EMCREG-International Monograph you will find a detailed discussion regarding the treatment of this important disease entity, acute coronary syndrome (ACS), which impacts millions of patients across the United States each year. This is a “state of the art” Monograph for emergency physicians, cardiologists, and hospitalists which provides the evidence basis for the optimal approach to treating ACS.

In this EMCREG-International Monograph, Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease, you will find a detailed discussion regarding the treatment of these two critically important disease entities. For cardiologists, internists, family physicians, hospitalists and emergency physicians, the current approach and evolution of treatment for stable coronary artery disease (CAD) and peripheral artery disease (PAD) are particularly relevant and represent a fertile area for improving care for these patients.

In this EMCREG-International Monograph you will find a detailed discussion regarding the use of high sensitivity troponin assays in patients presenting to the hospital with ACS from multiple perspectives including Emergency Medicine, Cardiology, Hospital Medicine, Laboratory Medicine, and Emergency Nursing.

In this EMCREG-International Monograph, you will find a variety of cardiovascular articles which will hopefully be helpful to you in your practice of Emergency Medicine and Acute Care Medicine. These topics which are extremely important to emergency physicians, hospitalists, and other acute care providers such as physician assistants and nurse practitioners as they care for these often critically-ill patients.

Join faculty experts as they review Emergency Physicians and Hospitalists care daily for patients who are critically ill and injured. The management of these patients is often complex and requires detailed diagnostic and therapeutic information, as well as a thorough understanding of disease pathophysiology.

This monograph covers advances in cardiac biomarker diagnostics including high-sensitivity troponin assays and CT coronary angiography, novel anticoagulant therapy, advances in antiplatelet therapy which have been incorporated into the latest ACCF/AHA guidelines, the interventional cardiologists perspective, and novel diagnostics for determining a patient’s clotting status by thromboelastography.

Transcript monograph from the 2013 EMCREG-International Symposium held in Seattle, Washington on October 13, 2013. This is presented as an interactive piece which features discussion of the new 2012 ACCF/AHA Guideline for the Treatment of Non-ST-segment Elevation Myocardial Infarction and Unstable Angina and the 2013 ACCF/AHA Guideline for the treatment of ST-segment Elevation Myocardial Infarction. Emphasis will be placed on the antiplatelet and anticoagulant portion of the guidelines.

EMCREG–International is pleased to present this complimentary CME monograph covering the proceedings of our 2010 webcasts. The events and this monograph covered important current and emerging acute care topics including risk stratification of ACS, ACS anticoagulation, thienopyridine therapy, novel antiplatelet agents prasugrel and ticagrelor, hypertensive emergencies, the obesity epidemic, acute heart failure treatment, and acute stroke.

Heart Failure remains a common presentation in the emergency department. For the emergency physician clarifying the course of the universal complaint, shortness of breath, requires excellent clinical acumen combined with a clear understanding of the laboratory tests available to distinguish Heart Failure from other causes of dyspnea. Dr. Frank Peacock of the Cleveland Clinic authors an excellent discussion of the scientific basis for the use of the natriuretic peptide biomarkers in heart failure including future markers currently being investigated.

EMCREG–International is pleased to present this complimentary CME monograph covering the proceedings of our 2009 satellite symposium at the ACEP Scientific Assembly in Boston, MA. The monograph covers a number of important topics including acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, STEMI Regional Systems of Care, and medical-legal issues of acute stroke.

EMCREG–International is pleased to present this complimentary CME monograph providing up-to-date knowledge on the full spectrum of decision making and care for patients with acute coronary syndromes (ACS) including non-ST-segment elevation ACS (NSTE ACS) and ST-segment elevation myocardial infarction (STEMI), acute heart failure syndromes, pulmonary embolism and acute ischemic stroke.

Hypertension remains one of the most common disease processes in patients presenting to the Emergency Department (ED). While sometimes symptomatic and associated with end organ damage such as hypertensive encephalopathy, hemorrhagic stroke, acute coronary syndrome, heart failure, and renal insufficiency, many patients present without symptoms. Emergency physicians and hospitalists should understand the appropriate classification of patients with hypertension, the pathophysiology of this disease process, and appropriate treatment strategies. In this EMCREG-International Newsletter, Charles V. Pollack, Jr. MD and Christopher J. Rees, MD of Pennsylvania Hospital and the University of Pennsylvania discuss hypertension and parenteral medications used for treatment of these patients in the ED.

This supplement [Ann Emerg Med 2008;51(3 Suppl 1):S1-S38] represents the first supplement to Annals of Emergency Medicine in nearly 16 years! These consensus documents on the evaluation and management of hypertension and hypertensive emergencies in the ED was systematically developed between December 2006 and April 2007 in an evidence-based and consensus-based process and culminated in the March 2008 supplement of Annals. The panel members were selected from a multidisciplinary group of specialists, which included physicians from emergency medicine, neurology, neurological surgery, internal medicine, hospital medicine, nephrology, cardiology, pediatrics, anesthesiology, vascular surgery, and gynecology and obstetrics.

This EMCREG-International Newsletter describe historical and physical examination findings crucial for the evaluation of end organ damage. Also provided are descriptions of hypertension associated with the following disease processes: Asymptomatic Hypertension, Acute Coronary Syndrome, Acute Heart Failure Syndromes, Neurological Emergencies, Cocaine or Amphetamine Induced Hypertension, and Aortic Dissection are provided with treatment recommendations. Through collaboration with colleagues from a variety of specialties, patients with hypertension can receive optimal therapy when presenting to any acute care setting.

A number of important topics are covered in this monograph including acute coronary syndrome, the diagnosis of transient ischemic attack and stroke, the treatment of ischemic and hemorrhagic stroke, the management of hypertension in acute neurovascular emergencies, the management of hypertensive urgencies and emergencies, markers for severe bacterial infections, the treatment of sepsis, risk stratification of possible acute coronary syndrome, the optimal management of NSTEMI and STEMI, treatment of acute heart failure syndrome, and the diagnosis and treatment of deep venous thrombosis and pulmonary embolism.

Hypertensive emergencies represent one of the most common presentations to the emergency department, as many as 3% of visits in one study. For emergency physicians, early diagnosis and appropriate treatment are essential for minimizing injury due to elevated blood pressure. In some cases, this management of hypertension can be life saving. This Newsletter focuses on the drug treatment of hypertensive emergencies, primarily parenteral therapy. The drugs of choice for the treatment of each diagnostic category are discussed with the evidence supporting these recommendations.